FDA OKs Glaxo's inhaler, first one to combine three medicines
The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis.
Sep 19, 2017
0
161
The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis.
Sep 19, 2017
0
161
Drugmaker Pfizer says it's reducing what it charges humanitarian groups for its blockbuster vaccine against pneumonia, ear and blood infections.
Nov 11, 2016
0
0
Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the U.S. drugmaker valued at about $130 million.
Jun 22, 2015
0
3
Shares of cancer drug developer Adaptimmune fell Wednesday after the British company's initial public offering raised $191.3 million.
May 6, 2015
0
4
Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.
Apr 23, 2015
0
7
Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.
Mar 29, 2015
0
14
Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.
Dec 4, 2014
0
0
Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.
Jul 17, 2014
0
0
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more ...
Apr 22, 2014
0
0